
Since this is the first of this series, I'd welcome any comments and feedback. How do you think the industry will develop? And how do you think companies should adapt to these changes?
(Jun 25, 2010)Pharma execs need to discard conventional thinking and prepare their organizations for bursts of sudden, dramatic change, argues Brian Smith.
(Jul 20, 2010)Effective strategies must match both the external market and the internal company culture.
(Aug 16, 2010)*How the forces of globalization, demography, and technology are reshaping the pharma market *
(Oct 18, 2010)*How the rise of a major Indian or Chinese pharma player could dramatically change the industry*
(Dec 2, 2010)Kevin Appareti, global director for Medical Science Liaison at Philips Healthcare, explains how to motivate KOLs and how to measure their value
The Mobile Health Competition is now closed, but the journey is just beginning for the winning idea.
Phil Taylor reports on the commercial and scientific opportunities facing medical scientific liaisons (MSLs)
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs